Highlights 2006-2007
CSL Bioplasma Products
Annual Report Contents > Business Features > CSL Bioplasma Feature > CSL Bioplasma Products
banner


Major plasma-derived products manufactured and/or distributed by
CSL Bioplasma


Haemophilia and Other Coagulation Disorders

Coagulation therapies are used to treat bleeding disorders such as haemophilia
and von Willebrand disease.
Biostate® (human coagulation factor VIII)
MonoFix®-VF (human coagulation factor IX)
Prothrombinex®-VF (human prothrombin complex)

Critical Care Conditions

Critical care products are used in fluid resuscitation, for replacement of albumin,
and to treat specific factor deficiencies.

Albumex® (human albumin)
Thrombotrol®-VF (human antithrombin III)

Immune Disorders and Immune Therapy

Immunoglobulins are used to treat immunodeficiency, modify the function of the
immune system, and for protection against specific infections.

Intragam® P (6% liquid intravenous immunoglobulin)
Normal Immunoglobulin-VF (human normal immunoglobulin)
Rh(D) Immunoglobulin-VF (human Rh(D) immunoglobulin)
CMV Immunoglobulin-VF (human cytomegalovirus immunoglobulin)
Hepatitis B Immunoglobulin-VF (human hepatitis B immunoglobulin)
Zoster Immunoglobulin-VF (human zoster immunoglobulin)
Tetanus Immunoglobulin-VF (human tetanus immunoglobulin)
Sandoglobulin® NF Liquid (12% liquid intravenous immunoglobulin)
Sandoglobulin® NF Liquid is manufactured by CSL Behring and distributed in Australia by
CSL Bioplasma.

Diagnostic Products

Diagnostic products are used in the testing of blood to provide compatible blood
transfusions, and to indicate appropriate antivenom treatment.

ABD Monoclonal Reagents
Reagent Red Blood Cells
Snake Venom Detection Kit
Used to detect venom in snakebite victims and indicate the appropriate monovalent antivenom
for treatment.

Under Australia's Special Access Scheme, CSL Bioplasma distributes several
life-saving, plasma-derived products for the treatment of rare conditions.

Back | Next